Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Articles Tagged With:

  • The CD&D Interview - Robert Jarvik, MD - Heart pump pioneer

    Robert Jarvik, MD, is a name known to many, for his development of the Jarvik 7 and the drama that was the life and death of retired dentist Barney Clark, the person first implanted with that first artificial heart in 1982.
  • Pharma developments

    A U.S. physician insists that current regulatory policies should be strengthened to ensure acceptable cardiovascular safety of medicines primarily developed for non-cardiovascular applications.
  • New study finds in-hospital delays for defibrillation

    It has been fairly common to say that a shock with an automated external cardioverter (AED) must be given to someone experience cardiac arrest within a 10-minute window following initial attack.
  • Acquisitions

    Edwards Lifesciences; CardioVations Division of Ethicon; C.R. Bard; LeMaitre Vascular; Biomateriali; Sorin Group; MedCath; Heart Hospital of Lafayette; Heart Hospital of Acadiana; Volcano; CardioSpectra
  • Agreements

    Beckman Coulter; Thomas Jefferson University; Laboraf Diagnostica e Ricerca San Raffaele SpA; BioSphere Medical; DuPont Applied BioSciences; GE Healthcare; Draximage; Draxis Health; HemCon Medical Technologies; AutoMedx; Toshiba Medical Systems; TomTec Imaging Systems
  • Market updates

    Catheter ablation reduced the number of shocks delivered to patients who have defibrillators implanted after heart attacks, concluded a study published in late last month in the "New England Journal of Medicine".
  • Personnel File

    ATS Medical; Cambridge Heart; Coherex Medical; Escalon Medical; FlowCardia; Heartscape Technologies; InterCure; TherOx
  • St. Jude wins clearance for new EnSite Fusion modeling software

    St. Jude Medical (St. Paul, Minnesota) reported FDA clearance of its EnSite Fusion Registration Module, new software designed to aid in creating detailed heart models to facilitate the diagnosis and delivery of therapy for complex abnormal atrial heart rhythms, including atrial fibrillation (AF).
  • Product pipeline

    CryoCor (San Diego) reported the publication of a European study of atrial fibrillation (AF) patients treated with its Cardiac Cryoablation System to evaluate the role of atrial flutter (AFl) in the recurrence of AF and the effectiveness of an ablation strategy focused on isolating the pulmonary veins to treat the AF.
  • Childhood Obesity — A Looming Disaster

    This remarkable study is a population analysis of a huge cohort of children in Denmark who were followed, since 1930 or later, for the presence of coronary heart disease (CHD), and had all mandatory annual examinations at schools in Copenhagen. The study analyzed data from 277,000 children, aged 7-13.